Form 4: Corcept Therapeutics Director, G Leonard Baker Jr., Acquires 30,000 Stock Options

G Leonard Baker Jr., a director of Corcept Therapeutics, acquired 30,000 stock options on May 17, 2024.

Summary

• On May 17, 2024, G Leonard Baker Jr., a director of Corcept Therapeutics Inc. [CORT], acquired 30,000 stock options.
• The exercise price of these options is $28.09.
• The options become exercisable ratably in equal monthly installments over a one-year period, starting May 17, 2024.
• The expiration date for these options is May 16, 2034.
• Following the transaction, Baker directly owns 30,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director, which is a common practice.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the options suggests a continued relationship between the director and the company over the next year.

Industry Context

This is a routine disclosure of insider activity. Monitoring such filings helps investors gauge management and board sentiment towards the company's prospects.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment, as it aligns the director's interests with those of the shareholders.

Key Dates